Sildenafil, widely known as Viagra, is a phosphodiesterase type 5 (PDE5) inhibitor licensed in the UK for erectile dysfunction and pulmonary arterial hypertension. Many patients wonder whether sildenafil accumulates in the body with regular use, particularly when taken daily or frequently. Understanding how sildenafil is processed and eliminated is essential for safe, effective use. This article explains sildenafil's pharmacokinetics, clearance timeline, factors affecting metabolism, and the safety of regular use, providing evidence-based guidance aligned with UK clinical practice and MHRA-approved prescribing information.

How Sildenafil Works in Your Body

Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor licensed in the UK for erectile dysfunction (as Viagra and generics) and pulmonary arterial hypertension (as Revatio). The medication works by selectively blocking the PDE5 enzyme, which is responsible for breaking down cyclic guanosine monophosphate (cGMP) in smooth muscle cells. When PDE5 is inhibited, cGMP levels increase, leading to smooth muscle relaxation and improved blood flow to specific tissues.

In erectile dysfunction, sildenafil enhances the natural erectile response to sexual stimulation by increasing blood flow to the penile tissues. It is important to understand that sildenafil does not cause spontaneous erections—sexual arousal is still required for the medication to be effective. The usual starting dose is 50 mg taken as needed approximately one hour before sexual activity; your doctor may adjust this to 25 mg or 100 mg depending on how well it works and any side effects. Do not take sildenafil more than once per day. The drug typically begins working within 30 to 60 minutes of oral administration, with peak plasma concentrations reached approximately one hour after taking the tablet.

For pulmonary arterial hypertension, sildenafil (Revatio) relaxes the blood vessels in the lungs, reducing pulmonary arterial pressure and improving exercise capacity. The mechanism is similar, but the therapeutic target and dosing differ from its use in erectile dysfunction. Revatio is prescribed by specialists, usually at 20 mg three times daily.

Sildenafil is absorbed through the gastrointestinal tract following oral administration. Food, particularly high-fat meals, can delay absorption and reduce peak plasma concentrations, so you may wish to take it on an empty stomach if a rapid effect is desired. Once in the bloodstream, approximately 96% of sildenafil binds to plasma proteins, primarily albumin. The medication is then metabolised primarily in the liver by cytochrome P450 enzymes, particularly CYP3A4 and CYP2C9, before being eliminated from the body through faeces and urine.

How Long Does Sildenafil Stay in Your Body?

For once-daily erectile dysfunction dosing, sildenafil does not build up in your system with regular use. The medication has a relatively short half-life of approximately 3 to 5 hours in most individuals. The half-life refers to the time it takes for half of the drug concentration in your bloodstream to be eliminated. This means that after about 3 to 5 hours, half of the sildenafil dose you took will have been processed and removed from your body.

Following this pharmacokinetic principle, sildenafil is typically cleared from your system within 24 hours after a single dose. After approximately five half-lives—roughly 15 to 25 hours for most people—more than 95% of the medication will have been eliminated. This relatively rapid clearance means that each dose is essentially processed and removed before the next dose is taken when used once daily for erectile dysfunction.

For pulmonary arterial hypertension, where sildenafil (Revatio) is prescribed three times daily, there is mild accumulation to a steady state within 24 to 48 hours. Plasma concentrations at steady state are approximately 1.2 to 1.6 times higher than after a single dose. However, there is no progressive build-up beyond this steady state, and concentrations remain predictable and within therapeutic ranges with continued use.

The clinical effects of sildenafil may last somewhat longer than its presence in the bloodstream. Many men report that the medication's effects on erectile function can persist for 4 to 6 hours, though this varies considerably between individuals. This duration of action does not indicate drug accumulation; rather, it reflects the time needed for the physiological effects to diminish after the drug has exerted its peak action.

Clearance can be slower in older adults and in people with liver or severe kidney impairment, so the effects may last longer in these groups.

Factors That Affect Sildenafil Clearance

Several physiological and external factors can influence how quickly sildenafil is metabolised and eliminated from your body, potentially affecting both its efficacy and duration of action.

Age is a significant factor in sildenafil clearance. Older adults, particularly those over 65 years, typically experience reduced hepatic metabolism and renal function. Studies have shown that plasma concentrations of sildenafil can be substantially higher in elderly patients compared to younger adults taking the same dose. A lower starting dose (25 mg) may be considered in older adults.

Hepatic impairment substantially affects sildenafil metabolism. The liver is the primary site where sildenafil is broken down by cytochrome P450 enzymes. Patients with moderate to severe liver disease may experience significantly prolonged drug clearance. The Summary of Product Characteristics (SmPC) and British National Formulary (BNF) recommend starting with a 25 mg dose in patients with hepatic impairment and using the medication with caution. Severe hepatic impairment is generally not recommended due to limited data; specialist advice should be sought.

Renal function also plays a role, though less prominently than hepatic function. Approximately 13% of sildenafil and its metabolites are excreted through the kidneys. Patients with severe renal impairment (creatinine clearance <30 mL/min) may experience elevated plasma concentrations and should typically start with a lower dose (25 mg).

Drug interactions can significantly impact sildenafil clearance and safety:

• Nitrates and nicorandil: Sildenafil is absolutely contraindicated with nitrates (such as glyceryl trinitrate) or nicorandil, as the combination can cause severe, potentially life-threatening hypotension. Never use these medications together.

• Riociguat: Concomitant use with riociguat (another pulmonary hypertension treatment) is contraindicated.

• Alpha-blockers: If you are taking alpha-blockers for prostate problems or high blood pressure, ensure you are stable on your alpha-blocker therapy before starting sildenafil. Your doctor may start you on a lower dose (25 mg) and advise separating the timing of the two medications to reduce the risk of postural hypotension (dizziness on standing).

• Strong CYP3A4 inhibitors: Medications that strongly inhibit CYP3A4 enzymes—such as ritonavir, other protease inhibitors, ketoconazole, and itraconazole—can substantially reduce sildenafil metabolism, leading to much higher plasma concentrations. For erectile dysfunction, if you are taking ritonavir, the maximum sildenafil dose is 25 mg taken no more often than every 48 hours. Similar caution applies to other strong inhibitors; your doctor will adjust your dose accordingly.

• Moderate CYP3A4 inhibitors: Erythromycin and clarithromycin can also increase sildenafil levels; dose adjustment may be needed.

• CYP3A4 inducers: Rifampicin and similar enzyme inducers may accelerate sildenafil clearance, potentially reducing its effectiveness.

• Grapefruit juice: Grapefruit juice may increase sildenafil levels and should be avoided or used with caution.

Genetic variations in cytochrome P450 enzymes can also affect individual responses to sildenafil, though this is less commonly assessed in routine clinical practice.

Safety of Regular Sildenafil Use

Regular use of sildenafil, when prescribed appropriately and taken as directed, is generally considered safe for most men. Extensive clinical trials and post-marketing surveillance data spanning over two decades support its safety profile for both on-demand and daily use.

Common adverse effects are typically mild to moderate, transient, and related to the vasodilatory properties of the medication. According to the Summary of Product Characteristics, common side effects (occurring in 1 in 10 to 1 in 100 people) include headache, facial flushing, dyspepsia (indigestion), dizziness, and visual disturbances such as altered colour perception or increased light sensitivity. Nasal congestion is also reported. These effects do not indicate drug accumulation but rather represent the expected pharmacological effects of PDE5 inhibition in various tissues.

Cardiovascular considerations are paramount when assessing the safety of sildenafil use. The medication causes a mild, transient decrease in blood pressure. Sildenafil is contraindicated in patients for whom sexual activity is inadvisable, such as those with unstable angina or severe heart failure. It is also generally not recommended within six months after a heart attack or stroke. Men with cardiovascular disease require careful assessment before starting sildenafil; your GP or specialist will evaluate whether it is safe for you. For men with stable cardiovascular disease, sexual activity and sildenafil use may be appropriate following individual assessment and, where necessary, specialist cardiovascular input.

Key contraindications and cautions include:

• Nitrates or nicorandil: Absolutely contraindicated due to risk of severe hypotension.

• Riociguat: Contraindicated.

• Hypotension: Use with caution if your blood pressure is low (below 90/50 mmHg).

• History of non-arteritic anterior ischaemic optic neuropathy (NAION): Caution is advised.

• Hereditary retinal disorders: Such as retinitis pigmentosa; use with caution.

• Alpha-blockers: Ensure stability on alpha-blocker therapy and consider dose separation.

Dosing for erectile dysfunction: The usual starting dose is 50 mg taken as needed about one hour before sexual activity. Your doctor may adjust this to 25 mg or 100 mg based on how well it works and any side effects. Do not take sildenafil more than once per day.

Long-term safety data from patients taking sildenafil daily for pulmonary arterial hypertension demonstrate no evidence of cumulative toxicity or progressive adverse effects with continued use. Regular monitoring is not typically required for men taking sildenafil for erectile dysfunction, though underlying cardiovascular risk factors should be managed appropriately.

When to seek medical attention: Contact your GP or seek urgent medical care if you experience chest pain during sexual activity, priapism (erection lasting more than 4 hours), sudden vision loss, or sudden hearing loss. These rare but serious adverse effects require prompt evaluation. Additionally, if sildenafil becomes progressively less effective, this may indicate worsening underlying vascular disease requiring medical review rather than simply increasing the dose.

Reporting side effects: If you experience any side effects, talk to your doctor or pharmacist. You can also report suspected side effects directly via the MHRA Yellow Card scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Reporting helps provide more information on the safety of medicines.

Frequently Asked Questions